TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19

被引：3
|
作者：
Pena, Eduardo [1 ]
Ahmed, Saeed [2 ,3 ]
机构：
[1] VA Boston Healthcare Syst, Drug Dependence Treatment Ctr, Jamaica Plain, MA 02130 USA
[2] Boston Med Ctr, Boston, MA USA
[3] VA Boston Healthcare Syst, Boston, MA USA
来源：
ADDICTION | 2020年 / 115卷 / 10期
关键词：
Buprenorphine; naloxone; Covid-19; medication for opioid use disorder; methadone; MOUD; opioid treatment programs; OTPs; SAMHSA;
D O I：
10.1111/add.15143
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：1978 / 1979
页数：2
相关论文
共 50 条
  • [1] Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada
    Joudrey, Paul J.
    Adams, Zoe M.
    Bach, Paxton
    Van Buren, Sarah
    Chaiton, Jessica A.
    Ehrenfeld, Lucy
    Guerra, Mary Elizabeth
    Gleeson, Brynna
    Kimmel, Simeon D.
    Medley, Ashley
    Mekideche, Wassim
    Paquet, Maxime
    Sung, Minhee
    Wang, Melinda
    Kheang, R. O. Olivier You
    Zhang, Jingxian
    Wang, Emily A.
    Edelman, E. Jennifer
    JAMA NETWORK OPEN, 2021, 4 (07)
  • [2] Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic
    Dadiomov, David
    Trotzky-Sirr, Rebecca
    Shooshtari, Andrew
    Qato, Dima M.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 232
  • [3] Opioid use disorder and COVID-19: Implications for policy and practice
    Mitchell, Michaela
    Shee, Kameron
    Champlin, Kelly
    Essary, Alison C.
    Evans, Matthew
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2021, 34 (06): : 1 - 4
  • [4] Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2)
    Leppla, Idris E.
    Gross, Marielle S.
    JOURNAL OF ADDICTION MEDICINE, 2020, 14 (04) : E1 - E3
  • [5] The Odyssey of HOMER: Comparative Effectiveness Research on Medication for Opioid Use Disorder During the COVID-19 Pandemic
    Zittleman, Linda
    Westfall, John M.
    Sofie, Benjamin
    Lutgen, Cory
    Fernald, Douglas
    Hall, Tristen L.
    Hochheimer, Camille J.
    Murphy, Melanie
    Felzien, Maret
    Dickinson, L. Miriam
    Manning, Brian K.
    LeMaster, Joseph
    Nease Jr, Donald E.
    ANNALS OF FAMILY MEDICINE, 2024, 22 (05) : 444 - 450
  • [6] Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic
    Perry, Allison
    Wheeler-Martin, Katherine
    Hasin, Deborah S.
    Terlizzi, Kelly
    Mannes, Zachary L.
    Jent, Victoria
    Townsend, Tarlise N.
    Ii, John R. Pamplin
    Crystal, Stephen
    Martins, Silvia S.
    Cerd, Magdalena
    Krawczyk, Noa
    DRUG AND ALCOHOL DEPENDENCE, 2023, 253
  • [7] Leveraging Telehealth in the United States to Increase Access to Opioid Use Disorder Treatment in Pregnancy and Postpartum During the COVID-19 Pandemic
    Guille, Constance
    McCauley, Jenna L.
    Moreland, Angela
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (04): : 290 - 293
  • [8] Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs
    Austin, Anna E.
    Tang, Lu
    Kim, Joo Yeon
    Allen, Lindsay
    Barnes, Andrew J.
    Chang, Chung-Chou H.
    Clark, Sarah
    Cole, Evan S.
    Durrance, Christine Piette
    Donohue, Julie M.
    Gordon, Adam J.
    Huskamp, Haiden A.
    McDuffie, Mary Joan
    Mehrotra, Ateev
    Mohamoud, Shamis
    Talbert, Jeffery
    Ahrens, Katherine A.
    Applegate, Mary
    Hammerslag, Lindsey R.
    Lanier, Paul
    Tossone, Krystel
    Zivin, Kara
    Burns, Marguerite E.
    JAMA HEALTH FORUM, 2023, 4 (06): : E231422
  • [9] Is It Time to Revisit Remdesivir Use for Severe COVID-19?
    Taggarsi, Dipali Anand
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (09) : 983 - 984
  • [10] Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
    Currie, Janet M.
    Schnell, Molly K.
    Schwandt, Hannes
    Zhang, Jonathan
    JAMA NETWORK OPEN, 2021, 4 (04)
12345